Therapeutic peptides development
Peptimimesis has raised €700k across 1 funding round from 1 investor, most recently a Seed round in Mar 2017. Based in France; founded 2015; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-03-01 | Seed | €700k |
| Cap Innov'Est |
| View deal → |
